The development of orally bioavailable drug candidates is a key aspect of pharmaceutical research, emphasizing the need for robust physicochemical properties that support efficient absorption and therapeutic efficacy. This article examines two distinct molecules, C₁₃H₁₁NO and C₁₅H₁₆N₂O₂, which demonstrate favorable characteristics for oral bioavailability based on various pharmacokinetic parameters. By systematically analyzing the pharmacokinetic properties of these compounds, this article aims to provide insight into their suitability for further pharmacological optimization and therapeutic application, highlighting the importance of molecular design in advancing drug discovery efforts.